Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alpha lipoic acid for geographic atrophy in AMD
NCT02613572Phase 2Completed
- Sponsor
- University of Pennsylvania
- Start
- Nov 2015
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of alpha-lipoic acid in geographic atrophy (GA) and age-related macular degeneration (AMD), sponsored by University of Pennsylvania. Started Nov 2015; status: completed.
02
Drugs
alpha-lipoic acid
03
Conditions
geographic atrophy (GA)age-related macular degeneration (AMD)
Beyond the preview
Go deeper on NCT02613572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02613572.